Provided by Tiger Fintech (Singapore) Pte. Ltd.

Heron Therapeutics

1.84
+0.03001.66%
Post-market: 1.840.00000.00%16:18 EDT
Volume:1.15M
Turnover:2.07M
Market Cap:280.72M
PE:-32.79
High:1.86
Open:1.79
Low:1.75
Close:1.81
Loading ...

Heron Therapeutics Inc. to Report Second Quarter 2025 Financial Results

Reuters
·
29 Jul

Heron Therapeutics Holds Annual Stockholders Meeting

TIPRANKS
·
18 Jun

Heron Therapeutics Inc. Conducted Annual Stockholders Meeting

Reuters
·
18 Jun

HC Wainwright Initiates Coverage on Heron Therapeutics With Buy Rating, $6 Price Target

MT Newswires Live
·
09 Jun

Sector Update: Health Care Stocks Fall Late Afternoon

MT Newswires Live
·
07 May

Heron Settles Patent Litigation With Mylan Over Cinvanti, Aponvie; Shares Rise

MT Newswires Live
·
06 May

Heron Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
06 May

Heron Therapeutics Q1 EPS $0.01 Beats $(0.01) Estimate, Sales $38.90M Beat $37.42M Estimate

Benzinga
·
06 May

Heron Therapeutics Settles Patent Dispute with Mylan

TIPRANKS
·
06 May

BRIEF-Heron Therapeutics Announces Settlement With Mylan Related To Cinvanti® And Aponvie® Patent Litigations

Reuters
·
06 May

Heron Therapeutics Inc expected to post a loss of 1 cent a share - Earnings Preview

Reuters
·
02 May

Heron Therapeutics (HRTX) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

Zacks
·
29 Apr

Heron Therapeutics Appoints Mark Hensley as COO

TIPRANKS
·
29 Apr

Heron Therapeutics Names Mark Hensley as COO

MT Newswires Live
·
29 Apr

Heron Therapeutics Announces Appointment of Mark Hensley as Chief Operating Officer

PR Newswire
·
29 Apr

Heron Therapeutics Price Target Maintained With a $4.00/Share by Needham

Dow Jones
·
11 Apr

Exploring High Growth Tech Stocks In The US Market April 2025

Simply Wall St.
·
05 Apr

Loss-Making Heron Therapeutics, Inc. (NASDAQ:HRTX) Expected To Breakeven In The Medium-Term

Simply Wall St.
·
29 Mar

Is Heron Therapeutics, Inc. (HRTX) The Hot Biotech Stock Under $5?

Insider Monkey
·
27 Mar

Heron Therapeutics, Inc. (NASDAQ:HRTX) Just Reported Earnings, And Analysts Cut Their Target Price

Simply Wall St.
·
02 Mar